Objective Various studies examining the relationship between HER-2 over-expression and
the response to chemotherapy and clinical outcome in patients with osteosarcoma have …

e21504 Background: Osteosarcoma is a genetic complex disease and little is known about
the molecular mechanisms that lead to its aggressiveness. HER2 overexpression as a …

LI YG & GENG X.(2010) European Journal of Cancer Care 19, 313–316 A meta‐analysis on
the association of HER‐2 overexpression with prognosis in human osteosarcoma Various …

Numerous original clinical studies have attempted to investigate the prognostic value of
HER-2 overexpression in osteosarcoma, but the results of these studies are not consistent …

Background: The prognostic value of Her-2/ErbB-2 in patients with high-grade
osteosarcoma remains controversial. Hence, we aimed to investigate the effects of Her-2 …

Background Previous studies have evaluated the effect of human epidermal growth factor
receptor 2 (HER-2) expression on the metastasis of patients with osteosarcoma (OS) while …

BACKGROUND: Osteosarcoma and chondrosarcoma, remain the most common primary
bone tumours. Questions have been raised about the prognostic influence of HER-2 in bone …

Osteosarcomas accounts for 56% of bone tumors and 15% of all extra cranial solid tumors,
with as much as 50% occurring in patient under 20 years old. The present retrospective …

BACKGROUND: Osteosarcoma and chondrosarcoma, remain the most common primary
bone tumours. Questions have been raised about the prognostic influence of HER-2 in bone …

The major goals of translational research in osteosarcoma entail the identification of
prognostic factors and therapeutic targets. Given the relevance of epidermal growth factor …